Published in World J Surg on June 01, 2014
Effects of Donor Age and Cold Ischemia on Liver Transplantation Outcomes According to the Severity of Recipient Status. Dig Dis Sci (2016) 0.75
Is it worth discussing the feasibility of deceased donor liver transplantation in centers with a strong experience in living donor liver transplantation? World J Surg (2014) 0.75
Hospital volume and surgical mortality in the United States. N Engl J Med (2002) 25.79
Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med (1996) 22.46
Surgeon volume and operative mortality in the United States. N Engl J Med (2003) 16.97
HOMOTRANSPLANTATION OF THE LIVER IN HUMANS. Surg Gynecol Obstet (1963) 10.22
A comparison of tacrolimus (FK 506) and cyclosporine for immunosuppression in liver transplantation. The U.S. Multicenter FK506 Liver Study Group. N Engl J Med (1994) 4.22
The effect of the volume of procedures at transplantation centers on mortality after liver transplantation. N Engl J Med (1999) 4.03
Long-term survival after liver transplantation in 4,000 consecutive patients at a single center. Ann Surg (2000) 2.91
A new technique for biliary drainage in orthotopic liver transplantation utilizing the gall bladder as a pedicle graft conduit between the donor and recipient common bile ducts. Ann Surg (1976) 2.86
Improvement in survival associated with adult-to-adult living donor liver transplantation. Gastroenterology (2007) 2.72
Association of center volume with outcome after liver and kidney transplantation. Am J Transplant (2004) 1.92
A nonsimultaneous, extended, altruistic-donor chain. N Engl J Med (2009) 1.81
Improved outcome of adult recipients with a high model for end-stage liver disease score and a small-for-size graft. Liver Transpl (2009) 1.79
Analysis of long-term outcomes of 3200 liver transplantations over two decades: a single-center experience. Ann Surg (2005) 1.73
Right lobe living donor liver transplantation with or without venovenous bypass. Br J Surg (2003) 1.63
Liver transplantation: a small-volume unit experience. ANZ J Surg (2008) 1.39
Lessons learned from one hundred right lobe living donor liver transplants. Ann Surg (2004) 1.24
Interleukin-2 receptor antibody (basiliximab) for immunosuppressive induction therapy after liver transplantation: a protocol with early elimination of steroids and reduction of tacrolimus dosage. Liver Transpl (2004) 1.06
A decade of right liver adult-to-adult living donor liver transplantation: the recipient mid-term outcomes. Ann Surg (2008) 1.02
Survival after adult liver transplantation does not correlate with transplant center case volume in the MELD era. Am J Transplant (2006) 1.00
The use of cyclosporin A in clinical organ grafting. Ann Surg (1982) 0.93
Prophylaxis and treatment of recurrent hepatitis B after liver transplantation. Transplantation (2003) 0.82
Experience using extended criteria donors in first 100 cases of deceased donor liver transplantation in Japan. Transplant Proc (2012) 0.79
Baylor Regional Transplant Institute: an update on liver, kidney, and pancreas transplantation. Proc (Bayl Univ Med Cent) (2003) 0.78
A prospective randomized trial between Euro-Collins and University of Wisconsin solutions as the initial flush in hepatic allograft procurement. Transplantation (1992) 0.77
Deceased-donor liver transplantation: 10 years' experience at Change Gung Memorial Hospital-Kaohsiung Medical Center. Chang Gung Med J (2005) 0.76
Use of elderly donors (> 60 years) for liver transplantation. Asian J Surg (2004) 0.76
Analysis of differences in outcome of two European liver transplant centers. Transpl Int (2006) 0.76
Modulation of graft vascular inflow guided by flowmetry and manometry in liver transplantation. Hepatobiliary Pancreat Dis Int (2011) 0.76
First case of cadaveric liver transplantation in Japan. J Hepatobiliary Pancreat Surg (1999) 0.75
Long-term survival analysis of pure laparoscopic versus open hepatectomy for hepatocellular carcinoma in patients with cirrhosis: a single-center experience. Ann Surg (2013) 3.11
miR-130b Promotes CD133(+) liver tumor-initiating cell growth and self-renewal via tumor protein 53-induced nuclear protein 1. Cell Stem Cell (2010) 2.87
Recoding RNA editing of AZIN1 predisposes to hepatocellular carcinoma. Nat Med (2013) 2.70
Anterior approach versus conventional approach right hepatic resection for large hepatocellular carcinoma: a prospective randomized controlled study. Ann Surg (2006) 2.59
Hematopoietic chimerism in liver transplantation patients and hematopoietic stem/progenitor cells in adult human liver. Hepatology (2012) 2.47
11C-acetate and 18F-FDG PET/CT for clinical staging and selection of patients with hepatocellular carcinoma for liver transplantation on the basis of Milan criteria: surgeon's perspective. J Nucl Med (2013) 2.29
Failure of hepatitis B vaccination in patients receiving lamivudine prophylaxis after liver transplantation for chronic hepatitis B. J Hepatol (2005) 2.19
Pure Laparoscopic Hepatectomy Versus Open Hepatectomy for Hepatocellular Carcinoma in 110 Patients With Liver Cirrhosis: A Propensity Analysis at a Single Center. Ann Surg (2016) 2.14
Living donor liver transplantation: the Asian perspective. Transplantation (2014) 2.13
Impact of antiviral therapy on the survival of patients after major hepatectomy for hepatitis B virus-related hepatocellular carcinoma. Arch Surg (2011) 2.05
Wait and transplant for stage 2 hepatocellular carcinoma with deceased-donor liver grafts. Transplantation (2013) 2.00
Entecavir monotherapy is effective in suppressing hepatitis B virus after liver transplantation. Gastroenterology (2011) 1.89
Documented deaths of hepatic lobe donors for living donor liver transplantation. Liver Transpl (2006) 1.83
Fibroblast growth factor 21 protects against acetaminophen-induced hepatotoxicity by potentiating peroxisome proliferator-activated receptor coactivator protein-1α-mediated antioxidant capacity in mice. Hepatology (2014) 1.80
High-intensity focused ultrasound for hepatocellular carcinoma: a single-center experience. Ann Surg (2011) 1.79
Ischemia-reperfusion of small liver remnant promotes liver tumor growth and metastases--activation of cell invasion and migration pathways. Liver Transpl (2007) 1.69
Comparison of early endoscopic ultrasonography and endoscopic retrograde cholangiopancreatography in the management of acute biliary pancreatitis: a prospective randomized study. Clin Gastroenterol Hepatol (2005) 1.66
A randomized, controlled trial of postoperative adjuvant interferon therapy after resection of hepatocellular carcinoma. Ann Surg (2007) 1.63
Occult hepatitis B virus infection of donor and recipient origin after liver transplantation despite nucleoside analogue prophylaxis. Liver Transpl (2010) 1.59
Identification of hepatitis B virus-specific lymphocytes in human liver grafts from HBV-immune donors. Liver Transpl (2007) 1.58
Working up donors for high-urgency and elective adult-to-adult live donor liver transplantation. Liver Transpl (2007) 1.54
External drainage of pancreatic duct with a stent to reduce leakage rate of pancreaticojejunostomy after pancreaticoduodenectomy: a prospective randomized trial. Ann Surg (2007) 1.54
Survival analysis of high-intensity focused ultrasound therapy versus radiofrequency ablation in the treatment of recurrent hepatocellular carcinoma. Ann Surg (2013) 1.51
Outcomes of living donor liver transplantation for patients with preoperative type 1 hepatorenal syndrome and acute hepatic decompensation. Liver Transpl (2012) 1.49
Long-term biological consequences of donor right hepatectomy including the middle hepatic vein in adult-to-adult live donor liver transplantation. Liver Transpl (2006) 1.46
Extended hepatic resection for hepatocellular carcinoma in patients with cirrhosis: is it justified? Ann Surg (2002) 1.45
Paired donor interchange to avoid ABO-incompatible living donor liver transplantation. Liver Transpl (2010) 1.45
Natural history of untreated nonsurgical hepatocellular carcinoma. Am J Gastroenterol (2005) 1.41
Hepatitis B virus-specific CD4 T cell immunity after liver transplantation for chronic hepatitis B. Liver Transpl (2009) 1.41
Difference in tumor invasiveness in cirrhotic patients with hepatocellular carcinoma fulfilling the Milan criteria treated by resection and transplantation: impact on long-term survival. Ann Surg (2007) 1.38
Signal transducers and activators of transcription 5b activation enhances hepatocellular carcinoma aggressiveness through induction of epithelial-mesenchymal transition. Cancer Res (2006) 1.25
Liver transplantation for acute-on-chronic liver failure. Hepatol Int (2009) 1.23
Toward current standards of donor right hepatectomy for adult-to-adult live donor liver transplantation through the experience of 200 cases. Ann Surg (2007) 1.19
Estimating liver weight of adults by body weight and gender. World J Gastroenterol (2006) 1.17
Risk factors for biliary complications after liver transplantation. Arch Surg (2004) 1.16
Suppression of liver tumor growth and metastasis by adiponectin in nude mice through inhibition of tumor angiogenesis and downregulation of Rho kinase/IFN-inducible protein 10/matrix metalloproteinase 9 signaling. Clin Cancer Res (2010) 1.15
Recurrence of hepatocellular cancer after liver transplantation: the role of primary resection and salvage transplantation in East and West. J Hepatol (2012) 1.14
Increasing the recipient benefit/donor risk ratio by lowering the graft size requirement for living donor liver transplantation. Liver Transpl (2012) 1.14
Toll-like receptor-4 mediates obesity-induced non-alcoholic steatohepatitis through activation of X-box binding protein-1 in mice. Gut (2012) 1.10
Liver transplantation for chronic hepatitis B with lamivudine-resistant YMDD mutant using add-on adefovir dipivoxil plus lamivudine. Liver Transpl (2005) 1.10
Up-regulation of vascular endothelial growth factor (VEGF) in small-for-size liver grafts enhances macrophage activities through VEGF receptor 2-dependent pathway. J Immunol (2004) 1.08
Activation of interleukin-6-induced glycoprotein 130/signal transducer and activator of transcription 3 pathway in mesenchymal stem cells enhances hepatic differentiation, proliferation, and liver regeneration. Liver Transpl (2010) 1.08
Surgical outcomes in hepatocellular carcinoma patients with portal vein tumor thrombosis. World J Surg (2014) 1.07
Interleukin-2 receptor antibody (basiliximab) for immunosuppressive induction therapy after liver transplantation: a protocol with early elimination of steroids and reduction of tacrolimus dosage. Liver Transpl (2004) 1.06
The significance of acute phase small-for-size graft injury on tumor growth and invasiveness after liver transplantation. Ann Surg (2008) 1.05
Hepatic resection for incidentaloma. J Gastrointest Surg (2004) 1.04
Liver transplantation for combined hepatocellular cholangiocarcinoma. Asian J Surg (2007) 1.04
Can positron emission tomography with the dual tracers [11 C]acetate and [18 F]fludeoxyglucose predict microvascular invasion in hepatocellular carcinoma? Liver Transpl (2011) 1.04
FTY720 attenuates hepatic ischemia-reperfusion injury in normal and cirrhotic livers. Am J Transplant (2005) 1.03
Pancreaticoduodenectomy with en bloc portal vein resection for pancreatic carcinoma with suspected portal vein involvement. World J Surg (2004) 1.02
A decade of right liver adult-to-adult living donor liver transplantation: the recipient mid-term outcomes. Ann Surg (2008) 1.02
Management of carcinoma of the gallbladder: a single-institution experience in 16 years. J Surg Oncol (2008) 1.01
FTY720 suppresses liver tumor metastasis by reducing the population of circulating endothelial progenitor cells. PLoS One (2012) 1.01
Proline-rich tyrosine kinase 2 (Pyk2) promotes cell motility of hepatocellular carcinoma through induction of epithelial to mesenchymal transition. PLoS One (2011) 1.00
Liver transplantation for hepatocellular carcinoma in Asia. Oncologist (2007) 0.99
Operative outcomes of adult-to-adult right lobe live donor liver transplantation: a comparative study with cadaveric whole-graft liver transplantation in a single center. Ann Surg (2006) 0.99
Donor quality of life before and after adult-to-adult right liver live donor liver transplantation. Liver Transpl (2006) 0.98
Treatment strategy for recurrent hepatocellular carcinoma: salvage transplantation, repeated resection, or radiofrequency ablation? Liver Transpl (2013) 0.98
Outcome of laparoscopic versus open hepatectomy for colorectal liver metastases. ANZ J Surg (2012) 0.96
Changing paradigm in the management of hepatocellular carcinoma improves the survival benefit of early detection by screening. Ann Surg (2008) 0.96
Attenuation of small-for-size liver graft injury by FTY720: significance of cell-survival Akt signaling pathway. Am J Transplant (2004) 0.94
Tolerance of high-intensity focused ultrasound ablation in patients with hepatocellular carcinoma. World J Surg (2012) 0.94
A garlic derivative, S-allylcysteine (SAC), suppresses proliferation and metastasis of hepatocellular carcinoma. PLoS One (2012) 0.93
Survival analysis of patients with transplantable recurrent hepatocellular carcinoma: implications for salvage liver transplant. Arch Surg (2008) 0.93